Population-based incidence of myeloid malignancies: Fifteen years of epidemiological data in the province of Girona, Spain

Haematologica

Volumn 98, Issue 8, 2013, Pages

  Osca Gelis, Gemma ^a,b,c   Puig Vives, Montserrat ^a,b,c   Saez, Marc ^b,c   Gallardo, David ^d   Lloveras, Natalia ^d   Marcos Gragera, Rafael ^a,b,c  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

HAEMACARE project; Myeloid malignancies; WHO classification

Indexed keywords

AGED; CANCER REGISTRY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INCIDENCE; LETTER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; SPAIN; THROMBOCYTHEMIA; ADOLESCENT; ADULT; COHORT ANALYSIS; HAEMACARE PROJECT; HEALTH SURVEY; HEMATOLOGIC DISEASE; METHODOLOGY; MIDDLE AGED; MYELOID MALIGNANCIES; REGISTER; RETROSPECTIVE STUDY; STATISTICS; VERY ELDERLY; WHO CLASSIFICATION; YOUNG ADULT;

HAEMACARE PROJECT; MYELOID MALIGNANCIES; WHO CLASSIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELOPROLIFERATIVE DISORDERS; POPULATION SURVEILLANCE; REGISTRIES; RETROSPECTIVE STUDIES; SPAIN; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84881007810     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.084061     Document Type: Letter

References (15)

1. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol. 2007;18 Suppl 1:i3-i8.
2. Sant M, Allemani C, Tereanu C, de Angelis R., Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724-34.
3. Visser O, Trama A, Maynadie M, Stiller C, Marcos-Gragera R, de Angelis R, et al. Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer. 2012;48(17):3257-66.
4. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292-302.
5. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-51.
6. Phekoo KJ, Richards MA, Moller H, Schey SA. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica. 2006;91(10):1400-4.
7. Neukirchen J, Schoonen WM, Strupp C, Gattermann N, Aul C, Haas R, et al. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS-registry. Leuk Res. 2011;35(12):1591-6.
8. Maynadie M, Girodon F, Manivet-Janoray I, Mounier M, Mugneret F, Bailly F, et al. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France). Haematologica. 2011;96(1):55-61.
9. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109(8):1536-42.
10. Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood. 2008;112(1):45-52.
11. Broccia G, Deplano W, Dessalvi P, Giannico B, Luxi G, Chessa E, et al. Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence. Hematol Oncol. 2004;22(3):91-109.
12. Sanderson RN, Johnson PR, Moorman AV, Roman E, Willett E, Taylor PR, et al. Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia. Leukemia. 2006;20(3):444-50.
13. Girodon F, Bonicelli G, Schaeffer C, Mounier M, Carillo S, Lafon I, et al. Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study. Haematologica. 2009;94(6):865-9.
14. Schafer AI. Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia. Blood. 2006; 107(11):4214-22.
15. Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer. 2003;97(9):2229-35.